Glioblastoma brain tumors are notoriously difficult to treat, and the prognosis is poor for people with this type of brain cancer. However, a new study may have discovered a way to halt glioblastoma growth and increase patient survival.
Researchers at Boston Children's Hospital have successfully reversed Type 1 diabetes in a mouse model by infusing blood stem cells pretreated to produce more of a protein called PD-L1, which is deficient in mice (and people) with Type 1 diabetes.[…]
Yale University immunologist Kevan Herold recently spoke about a few of his newest diabetes patients to an unlikely audience: oncologists and cancer researchers. At the Society for Immunotherapy of Cancer's annual meeting in Oxon Hill, Maryland, Herold and other speakers[…]